4//SEC Filing
Spellman David A 4
Accession 0001562180-23-004253
CIK 0001517022other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 6:19 PM ET
Size
5.0 KB
Accession
0001562180-23-004253
Insider Transaction Report
Form 4
Spellman David A
SVP, CFO and Treasurer
Transactions
- Sale
Common Stock
2023-05-16$1.07/sh−63,567$67,890→ 446,483 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer pursuant to the Issuer's previously adopted "sell-to-cover" policy to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on June 8, 2022.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001733204
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 6:19 PM ET
- Size
- 5.0 KB